Venous Thromboembolism (VTE)
Current BC and Canadian guidelines, algorithms, tools, prescribing references and patient resources for nurse practitioners.
Reviewed by Joe Grafe Due
Review overdue
This page was due for review on November 2, 2027. Check the linked sources for newer versions before relying on it.
Key Sources¶
BC Guidelines - Venous Thromboembolism (2024)
adults 19 and over with hemodynamically stable DVT or PE: outpatient diagnosis and management of acute VTE
- Key Recommendations
- Wells Score for DVT (table)
- DVT Diagnosis Algorithm (figure)
- Wells Score and PERC Rule for PE
- PE Diagnosis Algorithm (figure)
- Most Commonly Used Anticoagulants
- Appendix A: Proximal and Distal DVT
- Appendix B: D-dimer Cut-off Values
- Appendix C: Medications for the Treatment and Prevention of Venous Thromboembolism
Thrombosis Canada - Clinical Guides: DVT and PE
national point-of-care guides by Thrombosis Canada members, reviewed for primary care by College of Family Physicians of Canada members; version dates as stated by Thrombosis Canada
- Deep Vein Thrombosis (DVT): Diagnosis (2025) — version 7 May 2025
- Deep Vein Thrombosis (DVT): Treatment (2025) — version 2 November 2025
- Pulmonary Embolism (PE): Diagnosis (2026) — version 11 July 2026
- Pulmonary Embolism (PE): Treatment (2025) — version 1 May 2025
- Venous Thromboembolism: Duration of Treatment (2026) — version 9 April 2026
McGill Journal of Medicine - Approach to: Venous Thromboembolism (2023)
Ramdani S. McGill J Med 21(1); open access
Further Resources¶
- BC Guidelines - Venous Thromboembolism (2024) · PDF — adults 19 and over with hemodynamically stable DVT or PE: outpatient diagnosis and management of acute VTE
Perinatal Services BC - Thrombotic Disorders (2023)
Perinatal and Newborn Health Hub; more on Pregnancy and Perinatal
Thrombosis Canada - Clinical Guides: other VTE topics
version dates as stated by Thrombosis Canada
- Superficial Thrombophlebitis, Superficial Vein Thrombosis (2026) — version 12 July 2026
- Cancer and Thrombosis (2024) — version 10 September 2024
- Pulmonary Embolism: High- and Intermediate-Risk (2026) — version 11 July 2026
- Post Thrombotic Syndrome (PTS) (2025) — version 15 October 2025
- Pregnancy: Diagnosis of DVT and PE (2026) — version 6 January 2026
- Pregnancy: Venous Thromboembolism Treatment (2025) — version 1 May 2025
- Air Travel-related Thrombosis (2026) — version 31 August 2026
- Thrombophilia: Factor V Leiden and Prothrombin Gene Mutation (2025) — version 30 April 2025
- Pediatric Thrombosis (2026) — version 30 March 2026
Choosing Wisely Canada - Internal Medicine Recommendations (2026)
includes testing for clotting disorders after a first DVT with a known precipitant
NICE - Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158) (2020)
International source: UK guidance, not Canadian.
Algorithms and Pathways¶
- Thrombosis Canada - Acute Management Algorithm: Deep Vein Thrombosis — interactive algorithm (tool version 22)
- Thrombosis Canada - Acute Management Algorithm: Pulmonary Embolism — interactive algorithm (tool version 22)
- Thrombosis Canada - Thrombophilia Testing Algorithm — interactive algorithm (tool version 22)
No Pathways BC or Alberta pathway for venous thromboembolism found.
Assessment Tools and Calculators¶
BC Guidelines - Appropriate Use of CT for Suspected Pulmonary Embolism in the Non-Pregnant Adult (2019)
part of Appropriate Imaging for Common Situations in Primary and Emergency Care
- Thrombosis Canada - Wells' Criteria for DVT — Canadian rule (Wells, Ottawa)
- Thrombosis Canada - Wells' Criteria for Pulmonary Embolism — Canadian rule (Wells, Ottawa)
- Thrombosis Canada - PERC Rule for Pulmonary Embolism — US rule
- Thrombosis Canada - Simplified PESI (Pulmonary Embolism Severity Index) — PE severity and outpatient treatment
- Thrombosis Canada - Khorana Risk Score for VTE in Cancer Patients — VTE risk in people with cancer
- More decision rules for chest pain and dyspnea — see Clinical Decision Rules
Prescribing¶
- DOAC and warfarin guidelines, switching anticoagulants and perioperative management — see Atrial Fibrillation and Anticoagulation
Thrombosis Canada - Clinical Guides: anticoagulants
drug guides with dosing by indication; version dates as stated by Thrombosis Canada
- Apixaban (Eliquis) (2025) — version 2 June 2025
- Rivaroxaban (Xarelto) (2025) — version 2 November 2025
- Edoxaban (2026) — version 11 July 2026
- Dabigatran (Pradaxa) (2026) — version 10 September 2026
- Unfractionated Heparin, Low Molecular Weight Heparin and Fondaparinux (2025) — version 30 April 2025
- DOACs in Patients with Obesity (2025) — version 30 April 2025
- DOACs: Management of Bleeding (2025) — version 16 October 2025
- Management of Heavy Menstrual Bleeding for Patients on Anticoagulation (2025) — version 29 May 2025
- RxFiles - Drug Comparison Charts: Oral Antithrombotic Agents · PDF — oral anticoagulants and antiplatelets compared; the chart needs an RxFiles subscription
PharmaCare Special Authority: criteria and request forms
low molecular weight heparins
Ontario Drug Benefit - Exceptional Access Program (EAP) (2026)
Ontario coverage for drugs not on the ODB Formulary; nurse practitioners submit requests through SADIE
Advice and Referral¶
- RACE - Rapid Access to Consultative Expertise — telephone and app advice from BC specialists for family physicians, nurse practitioners and midwives
- Pathways BC - Hematology — login; specialists and clinics, with referral details
- Ontario eConsult (OTNhub) — specialist advice for Ontario physicians and nurse practitioners, usually without a patient referral
Patient Resources¶
- HealthLink BC - Deep Vein Thrombosis
- HealthLink BC - Pulmonary Embolism
- Thrombosis Canada - You Have a DVT
- Thrombosis Canada - You Have a PE
Also known as: VTE, DVT, deep vein thrombosis, deep venous thrombosis, PE, pulmonary embolism, pulmonary embolus, blood clot, clot in leg, leg clot, swollen leg, calf pain, superficial thrombophlebitis, superficial vein thrombosis, phlebitis, post-thrombotic syndrome, Wells score, Wells criteria, PERC, D-dimer, sPESI, PESI, Khorana, compression ultrasound, CTPA, anticoagulant, anticoagulation, blood thinner, DOAC, apixaban, Eliquis, rivaroxaban, Xarelto, edoxaban, Lixiana, dabigatran, Pradaxa, LMWH, low molecular weight heparin, dalteparin, Fragmin, enoxaparin, Lovenox, tinzaparin, Innohep, warfarin, cancer-associated thrombosis, thrombophilia, factor V Leiden, travel clot, Thrombosis Canada